Skip to main content
. 2018 Jul 9;13(7):e0200023. doi: 10.1371/journal.pone.0200023

Fig 3. A comparison of the modified LANZA scores between those treated with COX-2-selective inhibitors and those treated with non-selective COX-1 and COX-2 inhibitors.

Fig 3

(a) A comparison of the modified LANZA scores between patients treated with and without NSAIDs. (b) A comparison of the modified LANZA score between patients treated with COX-2-selective inhibitors and non-selective COX-1 and COX-2 inhibitors. Value are shown as the mean±SEM. Data were analyzed using a t-test, *p<0.05, **p<0.01. NSAIDs, non-steroidal anti-inflammatory drugs; COX, cyclooxygenase. Celecoxib, etodolac and meloxicam are COX-2-selective NSAIDs.